0

Your cart is currently empty.

Shopping Cart Shop Vielight tech
0

Your cart is currently empty.

Vielight Logo
0

Your cart is currently empty.

Shopping Cart Shop Vielight tech

Clinical Trial Recruitment

Join Clinical Trials with Vielight Technology

Vielight Technology has anchored the most-published brain photobiomodulation (PBM) research in the field.

Explore Clinical Trials that are currently recruiting and learn how you could take part in advancing non-invasive brain health.

See published research

In collaboration with

Currently Recruiting

Mild Cognitive Impairment Ongoing
Recruiting Recruitment (n=60) Conducted with the

Neuro Gamma

Mild Cognitive Impairment (MCI) Clinical Trial Recruitment | University of Toronto | Unity Health Toronto | Vielight Neuro (n=60)

Toronto MCI clinical study seeks adults based in Toronto, aged 50+ and noticing memory changes (no diagnosis) to try a 12-week, non-drug photobiomodulation (near-infrared light) helmet. To check eligibility, contact 416-360-4000 ext. 47838 or [email protected]

In collaboration with the University of Toronto and Unity Health, St. Michael’s Hospital.

Join study Clinicaltrials.gov
Bipolar Disorder Ongoing
Recruiting Recruitment (n=40) Conducted with the

Neuro Gamma

Intranasal-Transcranial Photobiomodulation for Bipolar Depression

This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the study and will either receive active treatment with the Vielight RX Gamma or sham (inactive device). To check eligibility, contact [email protected]

In collaboration with Providence Care Hospital.

Email recruitment Clinicaltrials.gov
Depression Ongoing
Recruiting Ongoing Conducted with the

Neuro Gamma

Vielight Depression Study

Toronto bipolar depression clinical study seeks adults with bipolar disorder to take part in a 6-week, non-drug research trial using a wearable near-infrared light (photobiomodulation) device, the Vielight Neuro RX Gamma. Participants attend in-clinic sessions 5 days/week and may receive either the active device or an inactive (sham) device. To check eligibility, contact [email protected]

Vielight Inc.

Initiation visit Depression Study Brochure
Neuromodulation
Recruiting Conducted with the

Vielight Neuro Pro 2

Neuro Pro 2 EEG Research | Toronto

Vielight is now enrolling healthy adults in Toronto for an EEG study characterizing brain responses to photobiomodulation at variable stimulation frequencies 💡 Write to: [email protected] Participants wear an EEG cap alongside a Vielight Neuro Pro2 (810 nm) while brain activity is recorded during rest and a simple listening task. Participation involves a minimum of 3 visits, each up to 3 hours, at our Toronto HQ on Jarvis Street. Compensation is $100 per visit. Email us: [email protected]
Email us See poster
Recruiting
Recruiting

PBM Rise – Vielight Neuro and OuraRing | Cincinnati Houston Miami

Do you live with epilepsy? You may be eligible to take part in PBMRise, a research study with the Vielight Neuro and an Oura Ring, exploring whether photobiomodulation (PBM) may support brain health, stress resilience, and quality of life: Study sites: Cincinnati, OH | Houston, TX | Miami, FL | Warren, OH What participation involves: · Using the Vielight Neuro Pro 2 · Wearing the Õura ring day and night to track sleep, heart rate, temperature, and activity · Metabolic testing (blood, hair, and urine) to measure changes at a cellular level · EEG brain-wave assessments
Recruitment Link

Why join a Clinical Trial?

Participate in a structured, science-driven research study
Our studies are designed by professional researchers following strict ethical and medical protocols.

Qualified professionals will monitor your progress
All clinical studies with Vielight Technology are conducted under medical supervision.

Help advance photobiomodulation (PBM) science
Each participant contributes valuable insights that move the field forward, helping us refine PBM applications to support brain function and overall wellbeing.

0